CLOFIBRATE Drug Patent Profile
✉ Email this page to a colleague
When do Clofibrate patents expire, and what generic alternatives are available?
Clofibrate is a drug marketed by Banner Pharmacaps, Sandoz, Teva, Usl Pharma, and Watson Labs. and is included in five NDAs.
The generic ingredient in CLOFIBRATE is clofibrate. There are four drug master file entries for this compound. Additional details are available on the clofibrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CLOFIBRATE?
- What are the global sales for CLOFIBRATE?
- What is Average Wholesale Price for CLOFIBRATE?
Summary for CLOFIBRATE
US Patents: | 0 |
Applicants: | 5 |
NDAs: | 5 |
Raw Ingredient (Bulk) Api Vendors: | 1 |
Clinical Trials: | 8 |
DailyMed Link: | CLOFIBRATE at DailyMed |
Recent Clinical Trials for CLOFIBRATE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Laboratorios Grossman, S.A. | Phase 3 |
Instituto Nacional de Salud Publica, Mexico | Phase 3 |
Federal University of São Paulo | Phase 4 |
Medical Subject Heading (MeSH) Categories for CLOFIBRATE
Anatomical Therapeutic Chemical (ATC) Classes for CLOFIBRATE
US Patents and Regulatory Information for CLOFIBRATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Banner Pharmacaps | CLOFIBRATE | clofibrate | CAPSULE;ORAL | 073396-001 | Mar 20, 1992 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Usl Pharma | CLOFIBRATE | clofibrate | CAPSULE;ORAL | 070531-001 | Jun 16, 1986 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Sandoz | CLOFIBRATE | clofibrate | CAPSULE;ORAL | 072191-001 | May 2, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Teva | CLOFIBRATE | clofibrate | CAPSULE;ORAL | 072600-001 | Jul 25, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Watson Labs | CLOFIBRATE | clofibrate | CAPSULE;ORAL | 071603-001 | Sep 18, 1987 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |